The CIRM is a federal promotional agency which have been established to promote stem cell research for medical purposes. Therefore, a total of 3 billion US dollars is available for ten years. Since the end of 2009, the Federal Ministery of Education and Research (BMBF) has concluded an agreement with the CIRM under which an involvement of german researchers for applying for financial CIRM-support within the scope of cooperation projects is possible.

Eligible for funding are small and medium-sized enterprises, hospitals that specialize in regenerative therapies, as well as research facilities, which receive a basic funding through government and state.

The current funding round adresses in particular at stem cell research projects which are at an early stage towards effective therapy. In priciple, all researchers can make an application if they work on the field of regenerative medicine an stem cell research. Topical relevance to the announcement must be present.

According to the Forschungszentrum Jülich, researchers developing in vitro-models as a replacement for animal-use may include.

Applicants for the "Early Translational III Research Awards" have to presentate their concepts until August, 10th 2011. Deadline for the full-proposal is December, 15th 2011.

German contact partner is the project management organisation Jülich.

Forschungszentrum Jülich: http://www.ptj.de/regmed-d-usa

Contact partner:
Forschungszentrum Jülich
Dr. Bülent Genç
Phone: ++49 (0) 2461 61-5265
This email address is being protected from spambots. You need JavaScript enabled to view it.

Source: http://www.cirm.ca.gov/rfa/rfa-11-02-cirm-early-translational-awards-iii